Skip to main content
AmigoFish

Jefferies London 2026: A top biotech CEO (Roivant's Matt Gline) and top investor (Affinity Asset Advisors' Patrick Nosker) talk running biotech companies and investing in them

From BiotechTV - News · · 19 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

They discuss Roivant's structure and programs (a top holding of Affinity's) and how different investors view companies different ways. Plus, the ups and downs of biotech, and why it is rare for smaller biotech companies to grow into larger entities over the long run.

Back to BiotechTV - News · Report a problem